SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE
SIREN : 487629750
Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2005-12-20 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: DORMANS (51700), Marne
SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE : revenue, balance sheet and financial ratios
SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in DORMANS (51700),
this company of category PME
shows in 2025 a revenue of 2.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE (SIREN 487629750)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
2 668 834 €
2 715 873 €
2 459 636 €
2 562 701 €
2 438 695 €
2 559 545 €
2 517 624 €
2 339 170 €
2 383 293 €
2 300 789 €
Net income
210 665 €
208 484 €
217 536 €
277 920 €
182 223 €
1 083 482 €
164 896 €
146 682 €
183 602 €
162 785 €
EBITDA
272 125 €
285 081 €
265 841 €
354 822 €
235 546 €
287 034 €
221 918 €
194 652 €
257 161 €
247 344 €
Net margin
7.9%
7.7%
8.8%
10.8%
7.5%
42.3%
6.5%
6.3%
7.7%
7.1%
Revenue and income statement
In 2025, SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE achieves revenue of 2.7 M€. Revenue is growing positively over 10 years (CAGR: +1.7%). Slight decline of -2% vs 2024. After deducting consumption (2.0 M€), gross margin stands at 709 k€, i.e. a rate of 27%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 272 k€, representing 10.2% of revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 211 k€, i.e. 7.9% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2025)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
2 668 834 €
Gross margin (2025)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
708 593 €
EBITDA (2025)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
272 125 €
EBIT (2025)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
259 636 €
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
210 665 €
EBITDA margin (2025)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
10.2%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 5%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 86%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.4 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 8.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
4.94%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
86.383%
Cash flow / Revenue (2025)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
8.42%
Repayment capacity (2025)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
0.439
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
83.611
55.572
53.258
40.718
16.112
11.223
8.463
6.864
5.855
4.94
Financial autonomy
45.732
55.682
57.011
62.089
74.306
78.386
81.682
82.852
82.548
86.383
Repayment capacity
4.658
3.642
5.091
3.551
1.445
1.062
0.558
0.632
0.508
0.439
Cash flow / Revenue
7.291%
7.158%
5.657%
6.512%
6.87%
7.009%
10.438%
8.078%
8.161%
8.42%
Sector positioning
Debt ratio
4.942025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Excellent
In 2025, the debt ratio of SOCIETE D'EXERCICE LIBERA... (4.94) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
86.38%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Excellent+11 pts over 3 years
In 2025, the financial autonomy of SOCIETE D'EXERCICE LIBERA... (86.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.44 years2025
2023
2024
2025
Q1: 0.51 years
Med: 2.46 years
Q3: 6.17 years
Excellent
In 2025, the repayment capacity of SOCIETE D'EXERCICE LIBERA... (0.44) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 445.94. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.1x. Danger: operating income does not cover interest charges, unsustainable situation.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
445.941
Interest coverage (2025)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
0.117
Liquidity indicators evolution SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
211.549
242.0
266.564
291.562
247.447
257.352
320.316
334.272
329.505
445.941
Interest coverage
3.733
2.285
2.972
1.396
1.195
0.34
0.182
0.199
0.149
0.117
Sector positioning
Liquidity ratio
445.942025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent
In 2025, the liquidity ratio of SOCIETE D'EXERCICE LIBERA... (445.94) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
0.12x2025
2023
2024
2025
Q1: 0.0x
Med: 1.91x
Q3: 5.98x
Average
In 2025, the interest coverage of SOCIETE D'EXERCICE LIBERA... (0.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 3 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 33 days. Favorable situation: supplier credit is longer than customer credit by 30 days. Inventory turnover is 20 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 24 days of revenue, i.e. 175 k€ to permanently finance. Notable WCR improvement over the period (-70%), freeing up cash.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
175 156 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
3 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
33 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
20 j
WCR in days of revenue (2025)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
24 j
WCR and payment terms evolution SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
588 542 €
552 519 €
666 453 €
707 478 €
122 090 €
203 363 €
156 402 €
193 401 €
226 314 €
175 156 €
Inventory turnover (days)
34
27
26
25
22
23
21
22
21
20
Customer payment term (days)
6
6
6
5
3
4
3
4
3
3
Supplier payment term (days)
46
35
40
41
36
41
33
41
44
33
Positioning of SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE is estimated at
2 205 591 €
(range 1 341 857€ - 3 139 839€).
With an EBITDA of 272 125€, the sector multiple of 7.7x is applied.
The price/revenue ratio is 0.61x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1341k€2205k€3139k€
2 205 591 €Range: 1 341 857€ - 3 139 839€
NAF 5 année 2025
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
272 125 €×7.7x
Estimation2 100 888 €
1 059 468€ - 3 058 454€
Revenue Multiple30%
2 668 834 €×0.61x
Estimation1 619 533 €
1 193 137€ - 1 868 027€
Net Income Multiple20%
210 665 €×15.9x
Estimation3 346 439 €
2 270 909€ - 5 251 023€
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE with other companies in the same sector:
Frequently asked questions about SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE
What is the revenue of SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE ?
The revenue of SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE in 2025 is 2.7 M€.
Is SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE profitable?
Yes, SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE generated a net profit of 211 k€ in 2025.
Where is the headquarters of SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE ?
The headquarters of SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE is located in DORMANS (51700), in the department Marne.
Where to find the tax return of SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE ?
The tax return of SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE operate?
SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart